Michael Erman
Japan Times
WORLD / Science & Health
Nov 16, 2021
Pfizer to allow generic versions of its COVID-19 pill in 95 countries
A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.
Japan Times
Jul 13, 2021
Pfizer bid for booster vaccines premature, experts say, with more data needed
The drugmaker's push for health regulators to authorize a third dose of its COVID-19 shot is not yet backed by evidence, despite the fast-spreading delta variant, vaccine experts said.
Japan Times
Jan 29, 2021
Racing the virus: Why tweaking vaccines to fight variants won't be simple
After developing and rolling out COVID-19 vaccines at record speed, drugmakers are already facing variants of the rapidly-evolving coronavirus that may render them ineffective.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD / Science & Health
Jul 10, 2020
Did bar reopenings lead to virus spikes? Probably. And protests? Probably not.
Over the past 3 months, millions of people have taken to the streets to protest against racism, while bars and restaurants have reopened around the world, as have some factories, food markets and even outdoor concerts.
Japan Times
Jun 9, 2014
Detroit rolls dice on casino-led comeback
Detroit's reliance on casino cash to help fund a recovery from the city's historic bankruptcy is a high-risk bet on an increasingly shaky source of income.


Traditional folk rituals like Mizudome-no-mai (dance to stop the rain) provide a sense of agency to a population that feels largely powerless in the face of the climate crisis.
As climate extremes intensify, Japan embraces ancient weather rituals